Impact 360 for Healthy Agers
Impact 360 Study for Healthy Agers
1 other identifier
interventional
60
1 country
1
Brief Summary
The Impact 360 study will evaluate the effects of a combined intervention of exercise, mindfulness, and nutrition on 8 key indicators of health and the mechanisms that drive these changes. 60 subjects aged 50 to 75 without a current diagnosis of a brain disorder will be recruited. This study will follow a partial crossover design. All participants will receive the intervention. Participants randomized into the intervention group after their baseline screening will receive the 6-month intervention. Those randomized into the waitlist group will complete another assessment at the end of the 6-month care as usual phase before receiving the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 24, 2024
CompletedFirst Submitted
Initial submission to the registry
May 3, 2024
CompletedFirst Posted
Study publicly available on registry
July 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 5, 2028
March 23, 2026
February 1, 2026
3.1 years
May 3, 2024
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (38)
Cognition - NIH Toolbox Cognitive Battery
Cognition will be measured using the National Institutes of Health (NIH) Toolbox Cognitive battery (NIHTB-CB). Testing is done pre- and post-intervention to compare scores.
6 Months
Cognition- Montreal Cognitive Assessment
Cognition will be measured using the Montreal Cognitive Assessment (MoCA). Testing is done pre- and post-intervention to compare scores.
6 Months
Cognition- Parkinson's Disease Cognitive Rating Scale
Cognition will be measured using the Parkinson's Disease Cognitive Rating Scale (PD-CRS). Testing is done pre- and post-intervention to compare scores.
6 Months
Inflammation and Biomarkers in Serum- High Sensitivity C-Reactive Protein
Systemic inflammation will be assessed by measuring concentrations of high sensitivity C-reactive protein (hs-CRP). Samples will be taken pre- and post-intervention to assess changes.
6 Months
Inflammation and Biomarkers in Serum - Interleukin-1β
Systemic inflammation will be assessed by measuring concentrations of interleukin-1β (IL-1β). Samples will be taken pre- and post-intervention to assess changes.
6 Months
Inflammation and Biomarkers in Serum - Interleukin-6
Systemic inflammation will be assessed by measuring concentrations of interleukin-6 (IL-6). Samples will be taken pre- and post-intervention to assess changes.
6 Months
Inflammation and Biomarkers in Serum - Tumour Necrosis Factor Alpha
Systemic inflammation will be assessed by measuring concentrations of Tumour Necrosis Factor Alpha (TNFa). Samples will be taken pre- and post-intervention to assess changes.
6 Months
Inflammation and Biomarkers in Serum - Interleukin-8
Systemic inflammation will be assessed by measuring concentrations of interleukin-8 (IL-8). Samples will be taken pre- and post-intervention to assess changes.
6 Months
Inflammation and Biomarkers in Serum - Interleukin-10
Systemic inflammation will be assessed by measuring concentrations of interleukin-10 (IL-10). Samples will be taken pre- and post-intervention to assess changes.
6 Months
Inflammation and Biomarkers in Serum - Interleukin-18
Systemic inflammation will be assessed by measuring concentrations of interleukin-18 (IL-18). Samples will be taken pre- and post-intervention to assess changes.
6 Months
Inflammation and Biomarkers in Serum - Calprotectin
Systemic inflammation will be assessed by measuring concentrations of calprotectin. Samples will be taken pre- and post-intervention to assess changes.
6 Months
Inflammation and Biomarkers in Serum - cortisol
Systemic inflammation will be assessed by measuring concentrations of cortisol. Samples will be taken pre- and post-intervention to assess changes.
6 Months
Microbiome Diversity
Stool samples will be analyzed for gut microbiome composition by shallow shotgun metagenome sequencing. Samples will be taken pre- and post-intervention to assess changes.
6 Months
Sleep Efficiency
Sleep efficiency (total sleep time/time spent in bed) will be measured through a wearable device with an accelerometer. This device will also measure other components of sleep quality such as sleep onset latency, total sleep time and wake after sleep onset.
6 Months
Pittsburgh Sleep Quality Index
The Pittsburgh Sleep Quality Index will be used to collect subjective sleep quality data on a monthly basis.
6 Months
Total Grey Matter Volume
Total grey matter volume will be measured using an MRI. Testing is done pre- and post-intervention to compares scores.
6 Months
Hippocampal Volume
Hippocampal volume will be measured using an MRI. Testing is done pre- and post-intervention to compares scores.
6 Months
White matter hyperintensities volume
White matter hyperintensities volume will be measured using an MRI. Testing is done pre- and post-intervention to compares scores.
6 Months
Myelin Water
Myelin water imaging will be collected using resting state functional MRI. Testing is done pre- and post-intervention to compares scores.
6 Months
Functional MRI
A flanker task will be administered during the MRI to examine selective attention, inhibitory function, and executive control. Testing is done pre- and post-intervention to compares scores.
6 Months
Maximal oxygen consumption (VO2 Max)
Predicted maximal oxygen consumption will be measured using a six-minute walk test. Testing is done pre- and post-intervention to compares scores.
6 Months
Heart Rate Recovery
Heart rate recovery will be measured using a three-minute step test. Testing is done pre- and post-intervention to compares scores.
6 Months
Berg Balance Assessment
A Berg Balance Assessment will be used to measure participants balance. Testing is done pre- and post-intervention to compares scores.
6 Months
Dynamic Gate Index
The Dynamic Gait Index will be used to measure participants gait. Testing is done pre- and post-intervention to compares scores.
6 Months
Timed Up and Go Test
The Dynamic Gait Index will be used to measure participants gait. Testing is done pre- and post-intervention to compares scores.
6 Months
30 Second Sit to Stand Test
Functional lower extremity strength with be assessed using the 30 second sit to stand test. Testing is done pre- and post-intervention to compare scores.
6 Months
Dual-Energy X-Ray Absorptiometry (DEXA)
Body composition, such as body fat and muscle mass, will be measured using Dual-energy X-ray Absorptiometry. Testing is done pre- and post-intervention to compare scores.
6-Months
Physical Activity Levels
Physical activity levels will be measured through a wearable device to help ensure adherence and effectiveness of the exercise intervention. Data will be collected throughout the study.
6 Months
Heart Rate
Heart rate will be measured through a wearable device to help ensure adherence and effectiveness of the exercise intervention. Data will be collected throughout the study.
6 Months
Fried Frailty Index
Physical frailty will be assessed using the fried frailty index. Testing is done pre- and post-intervention to compares scores.
6 Months
Blood Pressure
Blood pressure will be measured pre- and post-intervention to compares scores.
6 Months
Weight
Weight will be measured pre- and post-intervention to compares scores.
6 Months
Framingham Risk Score
Cardiovascular health will be assessed using the Framingham Risk Score. This score includes measurements of age, total cholesterol, smoking status, HDL level, diabetes status, systolic blood pressure and treatment status. Testing is done pre- and post-intervention to compares scores.
6 Months
NIH Toolbox- Emotional Battery
Social, emotional, and mental well-being will be evaluated using the NIH Toolbox-Emotional Battery. Testing is done pre- and post-intervention to compares scores.
6 Months
World Health Organization (WHO) Quality of Life Questionnaire
Quality of life will be evaluated using the World Health Organization (WHO) Quality of Life Questionnaire. Testing is done pre- and post-intervention to compares scores.
6 Months
Freiburg Mindfulness Inventory
Questionnaires related to mindfulness will be administered throughout the study at monthly intervals.
6 Months
Mindful Attention Awareness Scale
Questionnaires related to mindfulness will be administered throughout the study at monthly intervals.
6 Months
Multidimensional Assessment of Interoceptive Awareness
Questionnaires related to mindfulness will be administered throughout the study at monthly intervals.
6 Months
Study Arms (2)
Exercise, Diet, Mindfulness
EXPERIMENTALThe intervention group will start the intervention immediately following their baseline assessment. They will undergo another assessment after the 6 month intervention period.
Waitlist Group
NO INTERVENTIONParticipants randomized into the waitlist group will undergo a baseline assessment, and will then be encouraged to continue their daily activities as usual for 6 months. Physical activity and sleep will be monitored during this time using wearable devices. Links to questionnaires will be emailed monthly. After the 6-month waitlist period, participants will undergo a second assessment prior to starting the intervention. The multimodal intervention will be 6-months in length, using the same measures of adherence, and will be followed by a final assessment.
Interventions
The intervention will involve online (via University of British Colombia (UBC) Zoom videoconferencing) 1-hour moderate to high intensity exercise classes 3 times a week for 6 months
The intervention will involve 15 minute guided mediation following exercise classes as well as mindfulness classes. Mindfulness classes will consist of 1.5 hour Mindfulness Based Stress Reduction (MBSR) classes for the first 2 months, followed by 1 month of 1 hour bi-weekly discussions and practice, then MBSR 2.0 for months 4 and 5, and 1 hour bi-weekly discussions and practice for the remaining month of the intervention.
The intervention will involve biweekly 1-hour nutrition and cooking classes with a dietician.
Eligibility Criteria
You may qualify if:
- Participants who are able to complete questionnaires and follow directions for interventions
- Have access to a smartphone that can support the Fitbit app
You may not qualify if:
- Any neurological disease/disorder diagnosis (Ex: Parkinson's Disease, Multiple Sclerosis, Traumatic Brain Injury, Brain lesion, Stroke, etc)
- Any chronic medical condition which would affect ability to participate in exercise
- Any contraindication for exercise based on the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and medical clearance form
- Participants who were told by a medical doctor that they need to be medically supervised for exercise
- Montreal Cognitive Assessment (MoCA) scores \<21/30
- Significant cognitive impairment, depression, or eating disorder
- Any contraindication to MRI scanning; such as implanted metal clips or wires (see list below)
- Participants currently doing 180 minutes or more of moderate-vigorous intensity exercise per week AND either of the following:
- Completion of an Mindfulness-Based Stress Reduction course OR; Score \>8/15 in the Mediterranean-Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) Diet Questionnaire
- Significant or unstable cardiovascular or respiratory disease
- Severe/multiple head trauma(s)
- Subjects who are pregnant or breastfeeding
- Subjects with a history or major episodes of drug or alcohol abuse
- Chronic/acute bacterial/viral infection
- GI cancer
- +16 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of British Colombia
Vancouver, British Columbia, V6T 1Z3, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Silke Appel-Cresswell, MD, FRCPC
University of British Colombia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 3, 2024
First Posted
July 23, 2024
Study Start
January 24, 2024
Primary Completion (Estimated)
February 20, 2027
Study Completion (Estimated)
January 5, 2028
Last Updated
March 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share